Literature DB >> 14138757

THE EFFECT OF N,N-DIMETHYLTRYPTAMINE IN HUMAN SUBJECTS TOLERANT TO LYSERGIC ACID DIETHYLAMIDE.

D E ROSENBERG, H ISBELL, E J MINER, C R LOGAN.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE; CLINICAL RESEARCH; DRUG TOLERANCE; INDOLES; LYSERGIC ACID DIETHYLAMIDE; PHARMACOLOGY; PULSE; PUPIL; REFLEX; TRYPTAMINES

Mesh：

Substances：

Year:  1964        PMID： 14138757     DOI： 10.1007/BF00413244

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  7 in total

1.  THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE.

Authors:  H E HILL; C A HAERTZEN; A B WOLBACH; E J MINER
Journal:  Psychopharmacologia       Date:  1963-05-15

2.  OBSERVATIONS ON DIRECT AND CROSS TOLERANCE WITH LSD AND D-AMPHETAMINE IN MAN.

Authors:  D E ROSENBERG; A B WOLBACH; E J MINER; H ISBELL
Journal:  Psychopharmacologia       Date:  1963-10-24

3.  COMPARISON OF A PLACEBO, N-DIMETHYLTRYPTAMINE, AND 6-HYDROXY-N-DIMETHYLTRYPTAMINE IN MAN.

Authors:  D E ROSENBERG; H ISBELL; E J MINER
Journal:  Psychopharmacologia       Date:  1963-02-22

4.  Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.

Authors:  A B WOLBACH; H ISBELL; E J MINER
Journal:  Psychopharmacologia       Date:  1962-03-12

5.  Cross tolerance between LSD and psilocybin.

Authors:  H ISBELL; A B WOLBACH; A WIKLER; E J MINER
Journal:  Psychopharmacologia       Date:  1961

6.  Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.

Authors:  R E BELLEVILLE; H F FRASER; H ISBELL; C R LOGAN; A WIKLER
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-11

7.  Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs.

Authors:  C A WINTER; L FLATAKER
Journal:  J Pharmacol Exp Ther       Date:  1950-03       Impact factor: 4.030
  7 in total
  14 in total

1.  Indoles.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

2.  Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

Authors:  Katherine A MacLean; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2011-09-28       Impact factor: 4.153

3.  Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.

Authors:  Roland R Griffiths; Matthew W Johnson; William A Richards; Brian D Richards; Una McCann; Robert Jesse
Journal:  Psychopharmacology (Berl)       Date:  2011-06-15       Impact factor: 4.530

4.  Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.

Authors:  R R Griffiths; W A Richards; U McCann; R Jesse
Journal:  Psychopharmacology (Berl)       Date:  2006-07-07       Impact factor: 4.530

5.  Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat.

Authors:  B Colasanti; N Khazan
Journal:  Psychopharmacologia       Date:  1975-09-17

Review 6.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-01-20       Impact factor: 5.250

Review 7.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

Review 8.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

9.  Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.

Authors:  Rr Griffiths; Wa Richards; Mw Johnson; Ud McCann; R Jesse
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

10.  [Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)].

Authors:  A Dittrich; P Bickel; J Schöpf; D Zimmer
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.